Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective
Myopathy is the most common side effect of statins, but it has not been addressed effectively. In anticipation of its wider use as a small molecule to complement the current COVID-19 management, a pharmacological solution to statin-associated muscle symptoms (SAMS) is warranted. Statins act by suppr...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2023-11-01
|
| Edice: | Frontiers in Physiology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fphys.2023.1246589/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|